Impermeant antitumor sulfonylurea conjugates that inhibit plasma membrane NADH oxidase and growth of HeLa cells in culture. Identification of binding proteins from sera of cancer patients

Biochimica et Biophysica Acta - Biomembranes

Volumn 1324, Issue 2, 1997, Pages 171-181

  Kim, Chinpal ^a   MacKellar, Warren C ^b   Cho, NaMi ^a   Byrn, Stephen R ^a   James Morre D ^a  

^a PURDUE UNIVERSITY   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

Antitumor drug; Cyclodextrin; Diarylsulfonylurea; Drug conjugate; HeLa; Sulfonylurea

Indexed keywords

ALPHA CYCLODEXTRIN DERIVATIVE; ANTINEOPLASTIC AGENT; BINDING PROTEIN; LY 237868; MEMBRANE PROTEIN; PLASMA PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; SULFONYLUREA; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER PATIENT; CELL CULTURE; CELL SURFACE; CONJUGATE; CONTROLLED STUDY; DRUG PROTEIN BINDING; ENZYME INHIBITION; HELA CELL; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN ANALYSIS; SERUM; SPECTROPHOTOMETRY;

EID: 0030888946     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0005-2736(96)00219-2     Document Type: Article

References (22)

1. Morré, D.J., Morré, D.M., Stevenson, J., MacKellar, W. and McClure, D. (1995) Blochim. Biophys. Acta 1244, 133-140.
2. Morré, D.J., Wilkinson, F.E., Lawrence, J., Cho, N. and Paulik, M. (1995) Biochim. Biophys. Acta 1236, 237-243.
3. Morré, D.J., Wu, L.-Y. and Morré, D.M. (1995) Biochim. Biophys. Acta 1240, 11-17.
4. Morré, D.J. (1995) Biochim. Biophys. Acta 1240, 201-208.
5. Morré, D.J., Wilkinson, F.E., Kim, C., Cho, N. Lawrence, J., Morré, D.M. and McClure, D. (1996) Biochim. Biophys. Acta 1280, 197-206.
6. Morré, D.J. and Reust, T. (1997) J. Bioenerg. Biomemb. (submitted).
7. Howbert, J.J., Grossman, C.S., Crowell, T.A., Rieder, B.J., Harper, R.W., Kramer, K.E., Tao, E.V., Aikins, J., Poore, G.A., Rinzel, S.M., Grindey, G.B., Shaw, W.N. and Todd, G.C. (1990) J. Med. Chem. 33, 2393-2407.
8. Morré, D.J., Reust, T. and Morré, D.M. (1994) Methods Enzymol. 228, 448-450.
9. Butcher, L.A. and Tomkins, J.K. (1985) Anal. Biochem. 148, 384-388.
10. Morré, D.J. (1994) J. Biomemb. Bioenerg. 26, 421-433.
11. Morré, D.J., Jacobs, E., Sweeting, M., de Cabo, R. and Morré, D.M. (1997) Biochim. Biophys. Acta (in press).
12. Morré, D.J. and Morré, D.M. (1995) J. Biomemb. Bioenerg. 27, 137-144.
13. Tritton, T.R. and Yee, G. (1982) Science 217, 248-250.
14. Tökes, Z.A., Rogers, K.E. and Rembaum, A. (1982) Proc. Natl. Acad. Sci. USA 79, 2026-2030.
15. Wingard, W.B., Tritton, T.R. and Eyler, A.K. (1985) Cancer Res. 15, 3520-3536.
16. Rogers, K., Carr, E. and Tökes, Z. (1983) Cancer Res. 43, 2741-2748.
17. Seymour, L.W., Ulbrich, K., Strohalm, J., Kopecek, J. and Duncan, R. (1990) Biochem. Pharmacol. 39, 1125-1131.
18. Yeh, C.J. and Faulk, W.P. (1984) Clin. Immunol. Immunopathol. 32, 1-11.
19. Rogers, K. and Tökes, Z. (1984) Blochem. Pharmacol. 33, 605-608.
20. Faulk, W.P., Barabas, K., Sun, I.L. and Crane, F.L. (1991) Biochem. Int. 25, 815-822.
21. Faulk, W.P., Taylor, C.G., Yeh, C.J.G. and McIntyre, J.A. (1990) Mol. Biotherm. 2, 57-60.
22. Yeh, C.J.G., Taylor, C.G. and Faulk, W.P. (1984) Proteids. Biol. Fluids 32, 441-444.